Robert L Nussbaum insider trades: Invitae (NVTA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | NVTA | ↓ Sell | 7,086 | $1.38 | $10K | Direct | Jun 15, 2023 (2d) |
| May 16, 2023 | NVTA | ↓ Sell | 26,476 | $1.20 | $32K | Direct | May 18, 2023 (2d) |
| Mar 13, 2023 | NVTA | ↓ Sell | 2,625 | $1.41 | $4K | Direct | Mar 15, 2023 (2d) |
| Aug 16, 2022 | NVTA | ↓ Sell | 7,048 | $4.55 | $32K | Direct | Aug 18, 2022 (2d) |
| May 17, 2022 | NVTA | ↓ Sell | 6,098 | $3.81 | $23K | Direct | May 19, 2022 (2d) |
| Mar 14, 2022 | NVTA | ↓ Sell | 19,588 | $6.69 | $131K | Direct | Mar 16, 2022 (2d) |
| Nov 11, 2021 | NVTA | ↓ Sell | 29,675 | $21.89 | $650K | Direct | Nov 15, 2021 (4d) |
| Aug 16, 2021 | NVTA | ↓ Sell | 21,231 | $25.42 | $540K | Direct | Aug 18, 2021 (2d) |
| Jun 14, 2021 | NVTA | ↓ Sell | 9,910 | $31.63 | $313K | Direct | Jun 16, 2021 (2d) |
| Mar 12, 2021 | NVTA | ↓ Sell | 18,159 | $42.90 | $779K | Direct | Mar 17, 2021 (5d) |
| Sep 10, 2020 | NVTA | ↓ Sell | 23,175 | $33.56 | $778K | Direct | Sep 14, 2020 (4d) |
| Aug 19, 2020 | NVTA | ↓ Sell | 19,049 | $32.10 | $611K | Direct | Aug 20, 2020 (1d) |
| Jul 9, 2020 | NVTA | ↓ Sell | 29,783 | $34.15 | $1.0M | Direct | Jul 13, 2020 (4d) |
| May 22, 2020 | NVTA | ↓ Sell | 26,757 | $17.13 | $458K | Direct | May 22, 2020 (0d) |
| Mar 16, 2020 | NVTA | ↓ Sell | 10,684 | $11.79 | $126K | Direct | Mar 16, 2020 (0d) |
| Aug 19, 2019 | NVTA | ↓ Sell | 20,447 | $25.29 | $517K | Direct | Aug 21, 2019 (2d) |
| May 20, 2019 | NVTA | ↓ Sell | 7,202 | $18.21 | $131K | Direct | May 22, 2019 (2d) |
| Jan 10, 2019 | NVTA | ↓ Sell | 5,222 | $14.01 | $73K | Direct | Jan 14, 2019 (4d) |
| May 15, 2018 | NVTA | ↓ Sell | 6,702 | $6.96 | $47K | Direct | May 16, 2018 (1d) |
| Feb 15, 2017 | NVTA | ↓ Sell | 1,686 | $9.53 | $16K | Direct | Feb 15, 2017 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert L Nussbaum's insider trades
Robert L Nussbaum is Chief Medical Officer at Invitae (NVTA). Since Feb 15, 2017, Robert has reported no open-market purchases and 20 sales worth $6.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings), option exercises (6 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.